Dice Molecules Holdings Performance
| DICEDelisted Stock | USD 46.97 0.29 0.62% |
The firm shows a Beta (market volatility) of -0.69, which means possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Dice Molecules are expected to decrease at a much lower rate. During the bear market, Dice Molecules is likely to outperform the market. Dice Molecules Holdings right now shows a risk of 0.0%. Please confirm Dice Molecules Holdings jensen alpha, maximum drawdown, and the relationship between the coefficient of variation and sortino ratio , to decide if Dice Molecules Holdings will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Dice Molecules Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental indicators, Dice Molecules is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
| Begin Period Cash Flow | 116.2 M | |
| Total Cashflows From Investing Activities | 87.5 M |
Dice |
Dice Molecules Relative Risk vs. Return Landscape
If you would invest 4,697 in Dice Molecules Holdings on August 28, 2024 and sell it today you would earn a total of 0.00 from holding Dice Molecules Holdings or generate 0.0% return on investment over 90 days. Dice Molecules Holdings is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Dice, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Dice Molecules Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Dice Molecules' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Dice Molecules Holdings, and traders can use it to determine the average amount a Dice Molecules' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| DICE |
Based on monthly moving average Dice Molecules is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Dice Molecules by adding Dice Molecules to a well-diversified portfolio.
Dice Molecules Fundamentals Growth
Dice Stock prices reflect investors' perceptions of the future prospects and financial health of Dice Molecules, and Dice Molecules fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Dice Stock performance.
| Return On Equity | -0.22 | |||
| Return On Asset | -0.14 | |||
| Current Valuation | 2.27 B | |||
| Shares Outstanding | 47.76 M | |||
| Price To Book | 5.91 X | |||
| Price To Sales | 699.00 X | |||
| EBITDA | (83.01 M) | |||
| Cash And Equivalents | 282.22 M | |||
| Cash Per Share | 7.39 X | |||
| Total Debt | 13.27 M | |||
| Debt To Equity | 0.05 % | |||
| Book Value Per Share | 11.88 X | |||
| Cash Flow From Operations | (64.32 M) | |||
| Earnings Per Share | (2.17) X | |||
| Total Asset | 593.98 M | |||
| Retained Earnings | (187.59 M) | |||
About Dice Molecules Performance
By analyzing Dice Molecules' fundamental ratios, stakeholders can gain valuable insights into Dice Molecules' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Dice Molecules has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Dice Molecules has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. The company was incorporated in 2013 and is headquartered in South San Francisco, California. Dice Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 61 people.Things to note about Dice Molecules Holdings performance evaluation
Checking the ongoing alerts about Dice Molecules for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Dice Molecules Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Dice Molecules is not yet fully synchronised with the market data | |
| Dice Molecules has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (83.89 M) with loss before overhead, payroll, taxes, and interest of (56.08 M). | |
| Dice Molecules Holdings currently holds about 282.22 M in cash with (64.32 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.39. | |
| Over 97.0% of the company shares are held by institutions such as insurance companies |
- Analyzing Dice Molecules' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Dice Molecules' stock is overvalued or undervalued compared to its peers.
- Examining Dice Molecules' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Dice Molecules' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Dice Molecules' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Dice Molecules' stock. These opinions can provide insight into Dice Molecules' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in Dice Stock
If you are still planning to invest in Dice Molecules Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Dice Molecules' history and understand the potential risks before investing.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |